Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 562

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials

Voogd, Adri C., Nielsen, Maja, Peterse, Johannes L., Blichert-Toft, Mogens, Bartelink, Harry, Overgaard, Marie, van Tienhoven, Geertjan, Andersen, Knud West, Sylvester, Richard J., van Dongen, Joop A., for the Danish Breast Cancer Cooperative Group and the Breast Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer · 2001 · Journal of Clinical Oncology

Abstract

PURPOSE: Risk factors for local and distant recurrence after breast-conserving therapy and mastectomy were compared to define guidelines for the decision making between both treatments. PATIENTS AND METHODS: The data of two randomized clinical trials for stage I and II breast cancer patients were pooled. The total number of patients in the study was 1,772, of whom 879 underwent breast conservation, and 893, modified radical mastectomy. Representative slides of the primary tumor were available for histopathologic review in 1,610 cases (91%). RESULTS: There were 79 patients with local recurrence after breast-conservation and 80 after mastectomy, the 10-year rates being 10% (95% confidence interval [CI], 8% to 13%) and 9% (95% CI, 7% to 12%), respectively. Age no more than 35 years (compared with age >60: hazard ratio [HR], 9.24; 95% CI, 3.74 to 22.81) and an extensive intraductal component (HR, 2.52; 95% CI, 1.26 to 5.00) were significantly associated with an increased risk of local recurrence after breast-conserving therapy. Vascular invasion was predictive of the risk of local recurrence, irrespective of the type of primary treatment (P < .01). Tumor size, nodal status, high histologic grade, and vascular invasion were all highly significant predictors of distant disease after breast-conserving therapy and mastectomy (P < .01). Age no more than 35 years and microscopic involvement of the excision margin were additional independent predictors of distant disease after breast-conserving therapy (P < .01). CONCLUSION: Age no more than 35 years and the presence of an extensive intraductal component are associated with an increased risk of local recurrence after breast-conserving therapy. Vascular invasion causes a higher risk of local recurrence after mastectomy as well as after breast-conserving therapy and should therefore not be used for deciding between the two treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2001.19.6.1688

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 23

  1. 10.1016/0360-3016(86)90379-2 · doi:10.1016/0360-3016(86)90379-2
  2. 10.1016/S0167-8140(87)80016-6 · doi:10.1016/s0167-8140(87)80016-6
  3. 10.1016/S0360-3016(98)90004-9 · doi:10.1016/s0360-3016(98)90004-9
  4. 10.1002/(SICI)1097-0142(19980101)82:1<127::AID-CNCR15>3.0.CO;2-4 · doi:10.1002/(sici)1097-0142(19980101)82:1<127::aid-cncr15>3.0.co;2-4
  5. 10.1002/1097-0142(19891201)64:11<2217::AID-CNCR2820641106>3.0.CO;2-2 · doi:10.1002/1097-0142(19891201)64:11<2217::aid-cncr2820641106>3.0.co;2-2
  6. 10.1016/S0959-8049(99)00220-8 · doi:10.1016/s0959-8049(99)00220-8
  7. 10.1001/archsurg.1987.01400230034005 · doi:10.1001/archsurg.1987.01400230034005
  8. 10.1002/1097-0142(19900415)65:8<1867::AID-CNCR2820650833>3.0.CO;2-I · DOI
  9. 10.1002/1097-0142(19951201)76:11<2260::AID-CNCR2820761113>3.0.CO;2-D · doi:10.1002/1097-0142(19951201)76:11<2260::aid-cncr2820761113>3.0.co;2-d
  10. 10.1002/bjs.1800841119 · doi:10.1002/bjs.1800841119
  11. Veronesi U, Banfi A, Del Vecchio M, et al: Comparison of Halsted mastectomy with quadrantectomy, axillary dissection and radiotherapy in early breast cancer: Long-term results. Eur J Cancer Clin Oncol 9: 1085,1986-1089, · doi:10.1016/0277-5379(86)90011-8
  12. Nixon AJ, Schnitt S, Connolly JL, et al: Relationship of patient age to pathologic features of the tumor and the risk of local recurrence for patients with stage I or II breast cancer treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 24: 221,1992-232, · doi:10.1016/0360-3016(92)90294-r
  13. 10.1200/JCO.1990.8.1.113 · DOI
  14. 10.1002/1097-0142(19870215)59:4<675::AID-CNCR2820590402>3.0.CO;2-U · doi:10.1002/1097-0142(19870215)59:4<675::aid-cncr2820590402>3.0.co;2-u
  15. 10.1016/0360-3016(89)90056-4 · doi:10.1016/0360-3016(89)90056-4
  16. 10.1200/JCO.1991.9.6.997 · doi:10.1200/jco.1991.9.6.997
  17. 10.1002/bjs.1800821023 · doi:10.1002/bjs.1800821023
  18. 10.1002/bjs.1800840139 · doi:10.1002/bjs.1800840139
  19. 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8 · doi:10.1002/(sici)1097-0142(19960101)77:1<113::aid-cncr19>3.0.co;2-8
  20. 10.1016/S0002-9610(96)00227-9 · doi:10.1016/s0002-9610(96)00227-9
  21. 10.1002/1097-0142(19860401)57:7<1415::AID-CNCR2820570729>3.0.CO;2-K · doi:10.1002/1097-0142(19860401)57:7<1415::aid-cncr2820570729>3.0.co;2-k
  22. 10.1002/(SICI)1097-0142(19961001)78:7<1426::AID-CNCR8>3.0.CO;2-I · doi:10.1002/(sici)1097-0142(19961001)78:7<1426::aid-cncr8>3.0.co;2-i
  23. 10.1002/1097-0142(19860601)57:11<2217::AID-CNCR2820571124>3.0.CO;2-T · doi:10.1002/1097-0142(19860601)57:11<2217::aid-cncr2820571124>3.0.co;2-t

Cited by

See all 562

Metadata

Authors
Voogd, A. C., Nielsen, M., Peterse, J. L., Blichert-Toft, M., Bartelink, H., Overgaard, M., van Tienhoven, G., Andersen, K. W., Sylvester, R. J., van Dongen, J. A., & for the Danish Breast Cancer Cooperative Group and the Breast Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer
Venue
Journal of Clinical Oncology
Published
2001-03-15
Volume
19
Issue
6
Pages
1688-1697
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2254643376
Cited by
562
References
36
FWCI
6.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.